We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth [Yahoo! Finance]
MaxCyte, Inc. (MXCT)
Company Research
Source: Yahoo! Finance
Given this risk, we thought we'd take a look at whether MaxCyte LON:MXCT ) shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. First, we'll determine its cash runway by comparing its cash burn with its cash reserves. Does MaxCyte Have A Long Cash Runway? A company's cash runway is calculated by dividing its cash hoard by its cash burn. When MaxCyte last reported its June 2024 balance sheet in August 2024, it had zero debt and cash worth US$157m. Looking at the last year, the company burnt through US$25m. So it had a cash runway of about 6.2 years from June 2024. Even though this is but one measure of the company's cash burn, the thought of such a long cash runway warms our bellies in a comforting way. The image below shows how its cash balance has been changing over the last few years. How Well Is MaxCyte Growing? We reckon the fact that MaxCyte manage
Show less
Read more
Impact Snapshot
Event Time:
MXCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MXCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MXCT alerts
High impacting MaxCyte, Inc. news events
Weekly update
A roundup of the hottest topics
MXCT
News
- MaxCyte and Kamau Therapeutics sign platform license agreement [Yahoo! Finance]Yahoo! Finance
- MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic DiseasesGlobeNewswire
- MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing ConferenceGlobeNewswire
- MaxCyte (LON:MXCT) shareholders have earned a 22% CAGR over the last five years [Yahoo! Finance]Yahoo! Finance
- MaxCyte, Inc. (MXCT) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
MXCT
Earnings
- 8/6/24 - Beat
MXCT
Sec Filings
- 9/26/24 - Form 144
- 9/18/24 - Form 4
- 9/18/24 - Form 3
- MXCT's page on the SEC website